Coronary Artery Restenosis Completed Phase 4 Trials for Acetylsalicylic acid (DB00945)

Also known as: Restenosis, Coronary / Coronary Restenosis

IndicationStatusPhase
DBCOND0032386 (Coronary Artery Restenosis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01106534XIENCE V® USA Dual Antiplatelet Therapy (DAPT) CohortTreatment